Home
Home

Odanacatib

Merck Earnings Call Nuggets: Outcome of IMPROVE-IT and Filing Odanacatib

Merck Earnings Call Nuggets: Outcome of IMPROVE-IT and Filing Odanacatib
Wall Street Cheat Street

Merck says now anticipates odanacatib filing in 2014

Merck says now anticipates odanacatib filing in 2014
Yahoo/Fly on the Wall

5 Drug Hopefuls That Are Going to Change Your Life: Part 3

5 Drug Hopefuls That Are Going to Change Your Life: Part 3
Motley Fool

Will Merck's Odanacatib Sufficiently Fill Singulair's Void?

Will Merck's Odanacatib Sufficiently Fill Singulair's Void?
Motley Fool

Merck - How To Play This 'Patent Cliff' With Options

Merck - How To Play This 'Patent Cliff' With Options
Seeking Alpha

Merck osteoporosis drug builds bone density in mid-stage trial

Merck osteoporosis drug builds bone density in mid-stage trial
Reuters

Blockbuster buzz: 15 top therapies in late-stage development

Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech

The Market Has Already Discounted Merck's New Drug

The Market Has Already Discounted Merck's New Drug
Seeking Alpha

Merck Hits 4-Year High As Osteoporosis Drug Shines

Merck Hits 4-Year High As Osteoporosis Drug Shines
Investors.com

Merck 's odanacatib potential overlooked, says Credit Suisse

Merck 's odanacatib potential overlooked, says Credit Suisse
Yahoo/Fly on the Wall